Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:56 PM
Study NCT ID:
NCT01300793
Status:
TERMINATED
Last Update Posted:
2012-09-26
First Post:
2009-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-24
First Submit QC Date:
None
Study First Post Date:
2011-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-24
Last Update Post Date:
2012-09-26
Last Update Post Date Type:
ESTIMATED